ELMSFORD, N.Y., Feb. 19, 2013 /PRNewswire/ -- BioScrip
(NASDAQ: BIOS) today announced that the Company will release its
2012 fourth quarter and year-end financial results on Monday, March 11, 2013, after the market
closes.
(Logo: http://photos.prnewswire.com/prnh/20130117/NY44138LOGO
)
The Company will host a conference call at 8:30 a.m. Eastern Standard Time (EST) on
Tuesday, March 12, 2013. Richard Smith, President and Chief Executive
Officer, and Hai Tran, Chief
Financial Officer, will conduct the call.
Interested parties may participate in the conference call by
dialing 800-705-5308 (US), or 303-223-4377 (International), 5-10
minutes prior to the start of the call. A replay of the conference
call will be available for two weeks after the call's completion by
dialing 800-633-8284 (US) or 402-977-9140 (International) and
entering conference call ID number 21648877. An audio webcast and
archive will also be available under the "Investor Relations"
section of the BioScrip website at www.bioscrip.com.
About BioScrip, Inc.
BioScrip provides comprehensive infusion and home care
solutions. By partnering with patients, physicians, healthcare
payors, government agencies and pharmaceutical manufacturers we are
able to provide access to infusible medications and management
solutions. Our goal is to optimize outcomes for chronic and other
complex healthcare conditions and enhance the quality of patient
life. BioScrip brings clinical competence in providing high-touch,
comprehensive infusion and nursing services to patients in the most
convenient ways possible. Through our customer services and
treatments we aim to ensure the best possible therapy outcome.
SOURCE BioScrip, Inc.